Grossman, W.J., Revell, P.A., Lu, Z.H., Johnson, H., Bredemeyer, A.J., and Ley, T.J.: The orphan granzymes of humans and mice. Curr. Opin. Immunol. 2003, 15:544–552.
Lieberman, J.: The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 2003, 3:361–370.
Pipkin, M.E., and Lieberman, J.: Delivering the kiss of death: progress on understanding how perforin works. Curr. Opin. Immunol. 2007, 19:301–308.
Yasukawa, M., Ohminami, H., Arai, J., Kasahara, Y., Ishida, Y., and Fujita, S.: Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T lymphocytes in humans. Blood 2000, 95:2352–2355.
9-32 Cytotoxic T cells are selective and serial killers of targets expressing a specific antigen.
Stinchcombe, J.C., and Griffiths, G.M.: Secretory mechanisms in cell-mediated cytotoxicity. Annu. Rev. Cell Dev. Biol. 2007, 23:495–517.
Veugelers, K., Motyka, B., Frantz, C., Shostak, I., Sawchuk, T., and Bleackley, R.C.: The granzyme B-serglycin complex from cytotoxic granules requires dynamin for endocytosis. Blood 2004, 103:3845–3853.
9-33 Cytotoxic T cells also act by releasing cytokines.
Amel-Kashipaz, M.R., Huggins, M.L., Lanyon, P., Robins, A., Todd, I., and Powell, R.J.: Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8– and CD8+ T cells in systemic lupus erythematosus. J. Autoimmun. 2001, 17:155–163.
Dobrzanski, M.J., Reome, J.B., Hollenbaugh, J.A., and Dutton, R.W.: Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses. J. Immunol. 2004, 172:1380–1390.
Prezzi, C., Casciaro, M.A., Francavilla, V., Schiaffella, E., Finocchi, L., Chircu, L.V., Bruno, G., Sette, A., Abrignani, S., and Barnaba, V.: Virus-specific CD8+ T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection. Eur. J. Immunol. 2001, 31:894–906.
The Humoral Immune Response